The €1.2 Billion Question: Why Is ENI Receiving Major EU Financing Amid Legal and Antitrust Scrutiny?
In the space of less than a year, Eni S.p.A. has secured over €1.2 billion in public financing from European institutions—primarily the European Investment Bank—to support its transition into biofuels and renewable energy.
At the same time, one of its key subsidiaries, Novamont, has been at the center of a confirmed antitrust violation, while the group has faced mounting criticism and litigation from environmental actors.
This overlap raises a difficult but necessary question:
How closely are public financing decisions aligned with the legal and regulatory context of their recipients?
A Timeline Worth Examining
A review of publicly available information shows the following sequence:
- May 2023 — ~€50M EU grant for EV charging (Plenitude) (requires further public confirmation)
- June 2025 — Italy’s competition authority, the Autorità Garante della Concorrenza e del Mercato, confirms a €32M fine against Novamont and ENI for abuse of dominant position (2018–2023)
- July 2025 — €500M EIB loan for conversion of the Livorno refinery into a biorefinery
- September 2025 — €220M EIB-backed financing for GreenIT (renewables JV with Plenitude)
- April 2026 — €500M EIB loan for the Sannazzaro biorefinery
Taken together, these decisions amount to approximately:
€1.2 billion in public financing within a 12-month window
Notably, the first €500M loan was signed just one month after the antitrust fine was confirmed.
This does not prove a causal relationship. But it does establish a timeline that invites closer scrutiny.
The Legal Framework: Clear Rules, Unclear Application?
EU funding and public bank financing are not discretionary in the abstract—they are governed by legal and procedural constraints.
1. Compliance with EU Law
Under Regulation (EU) No 1303/2013, projects financed through EU instruments must comply with applicable Union law.
The confirmed violation of Article 102 TFEU by Novamont raises a legitimate question:
Were any publicly supported activities linked to the conduct covered by that infringement period (2018–2023)?
If so, this could have implications for compliance with the “legality condition” embedded in EU funding rules.
2. EIB Due Diligence Obligations
The European Investment Bank operates under its Environmental and Social Standards (2022), which require financed entities to comply with EU law—including competition law.
The key issue is not whether ENI can receive financing—it clearly can.
The question is narrower and more procedural:
How were ongoing or recently concluded antitrust proceedings factored into due diligence assessments for the 2025–2026 loans?
Public documentation does not currently provide a detailed answer.
3. The ESG Narrative and Disclosure Risk
ENI has positioned bio-based chemistry and biorefineries as part of its broader transition strategy, including within its sustainable finance framework.
If entities such as Novamont play a material role in that narrative, then their legal and financial profile becomes relevant to investors.
Under Regulation (EU) 2017/1129, disclosures must not omit material information that could affect investor decision-making.
This leads to a legitimate—if uncomfortable—question:
To what extent are legal risks, financial performance, and structural dependencies within subsidiaries fully reflected in sustainability-linked disclosures?
This is not an allegation of wrongdoing. It is a question of materiality and completeness.
4. Oversight and OLAF
The European Anti-Fraud Office has the authority to investigate potential misuse of EU funds under Regulation (EU) No 883/2013.
Situations that may warrant review can include:
- The coexistence of EU funding and confirmed regulatory violations
- Questions around asset valuation or project representation
- Allegations—by third parties—of litigation practices that may limit scrutiny
Whether any specific case meets the threshold for investigation is ultimately a matter for OLAF.
Coincidence, Timing—or a Governance Gap?
None of the elements above, taken individually, prove misconduct in the allocation of public financing.
But taken together, they highlight something else:
A potential gap between the speed of financial decision-making and the slower, often fragmented processes of regulatory enforcement.
Public banks like the EIB are central to Europe’s transition strategy. Their role is not only to deploy capital—but to do so in a way that is legally robust and publicly defensible.
When large-scale financing coincides with confirmed legal violations within the same corporate group, the burden is not necessarily on institutions to refuse funding—but to demonstrate how such risks were assessed and managed.
The Real Question
This is not ultimately about ENI alone.
It is about a broader systemic issue:
Can the EU ensure that its green transition financing is not only ambitious—but also legally and institutionally coherent?
Until that question is answered more transparently, cases like this will continue to raise eyebrows—and demand closer attention.
Summary of financial transactions from EU to ENI and its subsidiaries, entities, related organisations
NOTE:
The politically correct wording for ‘active SLAPP ongoing’ should be:
litigation described by critics as SLAPP
Source:
Disclaimer
This article is based on publicly available information, including official press releases, regulatory decisions, and corporate disclosures as of the date of publication. While every effort has been made to ensure accuracy, some information—particularly relating to timelines, financial amounts, and project scope—may be subject to updates, revisions, or differing interpretations.
The analysis presented reflects the author’s interpretation of the available data and relevant legal frameworks. It is intended for informational and journalistic purposes only and does not constitute legal, financial, or investment advice.
References to legal provisions, including Regulation (EU) No 1303/2013, Regulation (EU) 2017/1129, and Article 102 TFEU, are provided for context and do not represent definitive legal conclusions. Any statements regarding potential regulatory implications are speculative and framed as questions or considerations, not assertions of wrongdoing.
All entities mentioned, including ENI and its subsidiaries, are presumed to operate in compliance with applicable laws unless determined otherwise by competent authorities.
Readers are encouraged to consult original sources and seek professional advice where appropriate.
You must be logged in to post a comment.